Autopsy report · NCT01019980

Efficacy of Diclofenac Potassium Versus Acetaminophen in Febrile Children With Acute Upper Respiratory Tract Infections

“Placebo - Active Drug Not Available. No patients received drug. There are no study results to disclose.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• 2 participants enrolled.
• Results were posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Novartis Pharmaceuticals

Sponsor type

Industry

Conditions

Fever

Interventions

Diclofenac potassium; Acetaminophen

Participants

2

Sites

2

Countries

Venezuela

Trials that died the same way

• Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).
  “The study was terminated due to lack of efficacy compared to placebo.” (72% match in meaning)
• A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
  “One of the drugs for the study is not commercially available.” (65% match in meaning)
• Role of Oxytocin in Telling and Detecting Lies
  “Drug not available” (60% match in meaning)
• Iontophoresis in Psoriasis
  “FDA did not provide approval of the use of the drug for the study” (60% match in meaning)
• An Exploratory Clinical Study of Adebelimumab in Combination With Famitinib and Chemotherapy in Patients With NSCLC
  “The study drug, Famitinib, was not marketed and the drug was not available.” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.